Surfacide

10/24/2025

As we wrap up International Infection Prevention Week (IIPW), Surfacide is proud to stand with infection preventionists who work every day to protect patients, staff, and communities.

This year’s call to action — Stand UPPP for Infection Prevention — is a powerful reminder that infection prevention isn’t just a week, it’s a responsibility we uphold all year long.

At Surfacide, we’re committed to supporting healthcare teams with effective, evidence-based UV-C technology to reduce risk and enhance patient safety.

Thank you to the incredible professionals leading this mission — especially our partners at APIC - Infection Prevention and You

10/23/2025

We’re proud to be at the Georgia Infection Prevention Network’s 44th Annual Conference at Lake Lanier Islands Resort!

Stop by and see us during today’s Vendor Fair (11 a.m.–2 p.m.) to learn how Surfacide’s FDA authorized Helios+ UV-C System is setting the standard for whole room microbial reduction and supporting cleaner environments across healthcare.

10/20/2025

It’s Clean Hospitals Day 2025! This year’s theme — “Human Factors and Collaboration” — reminds us that infection prevention starts with people and teamwork.

As we also celebrate Infection Prevention Week, Surfacide proudly stands with healthcare professionals who work tirelessly to create safer, cleaner environments for patients and staff.

Because dirty surfaces are dangerous — and clean surfaces save lives. Together, we can make every surface count.

10/08/2025

🌟 There’s still time to nominate your Shining Star! 🌟

Do you know an Environmental Services professional who goes above and beyond to keep patients, staff, and visitors safe every day? Help us recognize their dedication and impact!

Nominations for the Surfacide Shining Star Scholarship Award are open until November 1.

One exceptional winner will receive a full registration to the 2026 AHE Exchange Summit in New Orleans.

Don’t wait—submit your nomination today: https://share.hsforms.com/1HTEP9mWKT-maMSaLEk7rMQct3b0

10/03/2025

We’re in Saint Louis today for the 29th Annual Bi-State Infectious Disease Conference!

Come see us at Booth 12 and meet John Paul from Surfacide to learn more about the Helios+® system — the only multi-emitter FDA-cleared Class II medical device for whole-room microbial reduction.

This important event, hosted by the Missouri-Illinois Public Health Officials and APIC Chapter 73, St. Louis MO, in collaboration with the Mayo Clinic Center for Tuberculosis, brings together healthcare leaders and infection prevention professionals from across the region.

If you’re attending, don’t miss the chance to connect with John Paul and see how Helios+ is setting a new standard for safer patient care.

APIC - Infection Prevention and You

09/19/2025

🌟 Nominate a Shining Star! 🌟

Surfacide is proud to honor the extraordinary environmental services (EVS) professionals who keep patients, staff, and visitors safe every single day.

Know an EVS team member who goes above and beyond?

Nominate them for the Surfacide Shining Star Scholarship Award!

One exceptional winner will receive a scholarship (up to $1,000 value) for full registration to the 2026 AHE Exchange Summit in New Orleans, August 16–19, 2026.

Help us celebrate the EVS heroes who are the frontline of infection prevention and care. 💙

Submit your nomination via our link in bio.

09/17/2025

This 2025, Surfacide joins the global call to ensure “Patient safety from the start!” Every child deserves safe, quality healthcare from their very first moments. With our advanced UV-C technology, we’re dedicated to creating cleaner, safer hospital environments to protect newborns, young children, and families worldwide.

Let’s act early, prevent harm, and build a healthier future for all.

09/15/2025

It’s EVS Week!!

Surfacide is proud to honor the extraordinary dedication of Environmental Services professionals—the unsung heroes who protect patients, staff, and visitors every day.

To celebrate, we’re now accepting nominations for our Shining Star Scholarship Award, recognizing EVS employees who go above and beyond. One outstanding winner will receive a full registration to the 2026 AHE Exchange Summit in New Orleans.

Know a Shining Star? Submit your nomination via 🔗 link in bio!

09/12/2025

For those in the Cincinnati–Dayton area, come say hello to Kim on the Surfacide team at the APIC Cincinnati–Dayton Chapter 26 Annual Conference today!

We’re proud to showcase Surfacide’s Helios+ UV-C system — FDA authorized for whole room microbial reduction. Stop by our table to learn how Helios+ stands out for being proven, effective infection prevention solution you can trust to get the job done.

09/11/2025

We’re proud to be back at the 2025 Annual Fleming Infection Prevention and Infectious Diseases Symposium, hosted by Lehigh Valley Health Network, as a three-time sponsor!

Stop by and meet Ryan on our team to learn more about Surfacide’s Helios+ UV-C system — an FDA-cleared Class II medical device for whole-room microbial reduction. We’ll also be sharing insights on the new regulatory requirements for UV-C in healthcare and what they mean for infection prevention leaders.

When it comes to patient safety, not all UV-C devices are created equal — FDA clearance matters.

09/05/2025

Thank you to Association for the Health Care Environment (AHE) for including part of our recent interview with Infection Control Today® in their newsletter.

In case you missed it, our CEO, Gunner Lyslo, discusses the regulatory complexities around UV-C technology and why it’s critical for hospitals to ask the right questions before investing in these devices.

Read the interview here: "UV Device Confusion: Why Hospitals Must Ask the Right Regulatory Questions" https://www.infectioncontroltoday.com/view/uv-device-confusion-why-hospitals-must-ask-the-right-regulatory-questions?

Thank you again to AHE for amplifying this important conversation on compliance and patient safety.

Are your UV-C disinfection systems FDA-compliant? Infection preventionists play a crucial role in ensuring devices meet regulatory standards. A simple conversation with your legal or compliance team today could prevent costly missteps tomorrow and help safeguard patient safety.

08/27/2025

Over the past few weeks, we’ve shared highlights from Surfacide Founder & CEO Gunner Lyslo’s interview with Infection Control Today’s Tori Whitacre Martonicz —spotlighting the regulatory clarity, patient safety impact, and industry standards behind FDA authorization of UVC devices.

Now, the entire interview is available to watch in full.

"FDA Authorization: Raising the Bar for UVC Disinfection in Health Care"
https://www.infectioncontroltoday.com/view/fda-authorization-raising-bar-uvc-disinfection-health-care

In this in-depth conversation, Gunner discusses:
- Why FDA authorization represents a new era in patient safety
- The rigorous testing and science that set Surfacide’s Helios®+ apart
- How health care leaders and infection preventionists can use regulatory benchmarks to guide purchasing decisions

This milestone isn’t just about Surfacide—it’s about raising the standard across the industry to ensure validated, trusted solutions are in place where they matter most: protecting patients.

As hospitals turn to UVC technology to combat health care-associated infections, a new FDA mandate is changing the game—requiring formal authorization for devices that claim to reduce microbial contamination. For infection preventionists and health care leaders, understanding this regulatory shift...